These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 12102580)

  • 41. Using pharmacogene polymorphism panels to detect germline pharmacodynamic markers in oncology.
    Hertz DL; McLeod HL
    Clin Cancer Res; 2014 May; 20(10):2530-40. PubMed ID: 24831276
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical implications of genomics for cancer risk genetics.
    Thomas DM; James PA; Ballinger ML
    Lancet Oncol; 2015 Jun; 16(6):e303-8. PubMed ID: 26065615
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of single nucleotide polymorphisms (SNPs) in understanding complex disorders and pharmacogenomics.
    Kao SL; Chong SS; Lee CG
    Ann Acad Med Singap; 2000 May; 29(3):376-82. PubMed ID: 10976393
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnosis and treatment of cancer using genomics.
    Vockley JG; Niederhuber JE
    BMJ; 2015 May; 350():h1832. PubMed ID: 26022222
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Impact of human genome analysis on the future medicine].
    Nakamura Y
    Nihon Yakurigaku Zasshi; 1999 Sep; 114(3):126-30. PubMed ID: 10553575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. What are SNPs and haplotypes and how will they help us manage the prevention of adult cancer?
    Velasquez JL; Lipkin SM
    Curr Oncol Rep; 2005 Nov; 7(6):475-9. PubMed ID: 16221385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacogenetics of cancer chemotherapy.
    Abraham J; Earl HM; Pharoah PD; Caldas C
    Biochim Biophys Acta; 2006 Dec; 1766(2):168-83. PubMed ID: 17141416
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Using bioinformatics and genome analysis for new therapeutic interventions.
    Mount DW; Pandey R
    Mol Cancer Ther; 2005 Oct; 4(10):1636-43. PubMed ID: 16227414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genomics and microarray for detection and diagnostics.
    Khan AS
    Acta Microbiol Immunol Hung; 2004; 51(4):463-7. PubMed ID: 15704334
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Integration of genomic technologies for accelerated cancer drug development.
    Basik M; Mousses S; Trent J
    Biotechniques; 2003 Sep; 35(3):580-2, 584, 586 passim. PubMed ID: 14513563
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression genomics and drug development: towards predictive pharmacology.
    Liu ET
    Brief Funct Genomic Proteomic; 2005 Feb; 3(4):303-21. PubMed ID: 15814022
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New drug targets for genomic cancer therapy: successes, limitations, opportunities and future challenges.
    Workman P
    Curr Cancer Drug Targets; 2001 May; 1(1):33-47. PubMed ID: 12188890
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Biochip technologies in cancer research.
    Kallioniemi OP
    Ann Med; 2001 Mar; 33(2):142-7. PubMed ID: 11327117
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of genomics on therapeutic drug development.
    Kennedy GC
    EXS; 2000; 89():1-10. PubMed ID: 10997279
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Application of industrial scale genomics to discovery of therapeutic targets in heart failure.
    Mehraban F; Tomlinson JE
    Eur J Heart Fail; 2001 Dec; 3(6):641-50. PubMed ID: 11738215
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacogenetics.
    Roses AD
    Hum Mol Genet; 2001 Oct; 10(20):2261-7. PubMed ID: 11673409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Methods: for studying pharmacogenetic profiles of combination chemotherapeutic drugs.
    Di Paolo A; Polillo M; Lastella M; Bocci G; Del Re M; Danesi R
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1253-67. PubMed ID: 26037261
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Highly parallel identification of essential genes in cancer cells.
    Luo B; Cheung HW; Subramanian A; Sharifnia T; Okamoto M; Yang X; Hinkle G; Boehm JS; Beroukhim R; Weir BA; Mermel C; Barbie DA; Awad T; Zhou X; Nguyen T; Piqani B; Li C; Golub TR; Meyerson M; Hacohen N; Hahn WC; Lander ES; Sabatini DM; Root DE
    Proc Natl Acad Sci U S A; 2008 Dec; 105(51):20380-5. PubMed ID: 19091943
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gene expression microarray technologies in the development of new therapeutic agents.
    Clarke PA; te Poele R; Workman P
    Eur J Cancer; 2004 Nov; 40(17):2560-91. PubMed ID: 15541959
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SNPs: At the origins of the databases of an innovative biotechnology tool.
    Corfield A; Meyer P; Kassam S; Mikuz G; Sergi C
    Front Biosci (Schol Ed); 2010 Jan; 2(1):1-4. PubMed ID: 20036923
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.